Improvement of local control of T3 and T4 nasopharyngeal carcinoma by hyperfractionated radiotherapy and concomitant chemotherapy (Q44002121)

28 November 2017

Improvement of local control of T3 and T4 nasopharyngeal carcinoma by hyperfractionated radiotherapy and concomitant chemotherapy (English)

1 reference

28 November 2017

James Jer-Min Jian

1

1 reference

28 November 2017

Skye Hongiun Cheng

2

1 reference

28 November 2017

Stella Yu-Chen Tsai

3

1 reference

28 November 2017

Kai-Cheng Lawrence Yen

4

1 reference

28 November 2017

Nei-Min Chu

5

1 reference

28 November 2017

Kwan-Yee Chan

6

1 reference

28 November 2017

Tran-Der Tan

7

1 reference

28 November 2017

Jason Chia-Hsien Cheng

8

1 reference

28 November 2017

Yen-Chun Lin

9

1 reference

28 November 2017

Szu-Yun Leu

10

1 reference

28 November 2017

Cheng-I Hsieh

11

1 reference

28 November 2017

Mei-Hua Tsou

12

1 reference

28 November 2017

Ching-Yuan Lin

13

1 reference

28 November 2017

Andrew T Huang

14

1 reference

28 November 2017

language of work or name

English

0 references

publication date

1 June 2002

1 reference

International Journal of Radiation Oncology Biology Physics

28 November 2017

1 reference

28 November 2017

53

1 reference

28 November 2017

2

1 reference

28 November 2017

344-352

1 reference

Staging of nasopharyngeal carcinoma: from Ho's to the new UICC system

28 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902709-8

7 January 2021

T classification and clivus margin as risk factors for determining locoregional control by radiotherapy of nasopharyngeal carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902709-8

7 January 2021

Computed tomography findings of bony regeneration after radiotherapy for nasopharyngeal carcinoma with skull base destruction: implications for local control

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902709-8

7 January 2021

Carcinoma of the nasopharynx: factors affecting prognosis

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902709-8

7 January 2021

Hyperfractionated radiation therapy in brain stem tumors. Results of treatment at the 7020 cGy dose level of Pediatric Oncology Group study #8495.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902709-8

7 January 2021

Hyperfractionation versus conventional fractionation in oropharyngeal carcinoma: final analysis of a randomized trial of the EORTC cooperative group of radiotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902709-8

7 January 2021

Hyperfractionated irradiation with or without concurrent chemotherapy for locally advanced head and neck cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902709-8

7 January 2021

Spinal cord dose from standard head and neck irradiation: implications for three-dimensional treatment planning

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902709-8

7 January 2021

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902709-8

7 January 2021

Improved local control for early T-stage nasopharyngeal carcinoma – a tale of two hospitals

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902709-8

7 January 2021

Prognostic features and treatment outcome in locoregionally advanced nasopharyngeal carcinoma following concurrent chemotherapy and radiotherapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902709-8

7 January 2021

Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: phase III randomized Intergroup study 0099

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902709-8

7 January 2021

Long-term survival of nasopharyngeal carcinoma following concomitant radiotherapy and chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902709-8

7 January 2021

Final report of a randomized trial on altered-fractionated radiotherapy in nasopharyngeal carcinoma prematurely terminated by significant increase in neurologic complications.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902709-8

7 January 2021

Partially hyperfractionated accelerated radiotherapy and concurrent chemotherapy for advanced nasopharyngeal carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902709-8

7 January 2021

Three-dimensional intensity-modulated radiotherapy in the treatment of nasopharyngeal carcinoma: the University of California-San Francisco experience.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902709-8

7 January 2021

Comparison of treatment plans involving intensity-modulated radiotherapy for nasopharyngeal carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902709-8

7 January 2021

Skull-base invasion of nasopharyngeal carcinoma: magnetic resonance imaging findings and therapeutic implications

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902709-8

7 January 2021

Nasopharyngeal carcinoma: MRI and CT assessment

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902709-8

7 January 2021

Examining prognostic factors and patterns of failure in nasopharyngeal carcinoma following concomitant radiotherapy and chemotherapy: impact on future clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902709-8

7 January 2021

10.1016/S0360-3016(02)02709-8

Identifiers

DOI

1 reference

28 November 2017

1 reference